Radiopharm Theranostics (RADX) has executed a subscription agreement for a private placement of ordinary shares to Lantheus Holdings (LNTH), raising $5M. The placement of 133 million shares was completed at an issue price of A$0.060 per share, representing a 150% premium to the last traded price of RAD shares. Settlement is expected to occur within 7 days. The placement replaces 6-month options that the Company issued in August 2024.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH: